Arachnoid cysts accompanied with psychiatric symptoms: Case series

2013 ◽  
Vol 14 (1) ◽  
pp. 87
Author(s):  
Sila Yazar ◽  
Nurhan Fistikci ◽  
Gulsum Canturk ◽  
Serap Oflaz ◽  
Ali Kucuktufekci ◽  
...  
Keyword(s):  
Psychiatric Symptoms ◽  
Case Series ◽  
Arachnoid Cysts

scholarly journals Cut it out or wait it out? Case series of middle fossa arachnoid cysts presenting with psychiatric symptoms and a discussion of the ethics of neurosurgical management

2021 ◽  
Vol 34 (6) ◽  
pp. e100523
Author(s):  
Petrus Johannes Steyn ◽  
Leigh Luella Van den Heuvel
Keyword(s):  
Psychiatric Symptoms ◽  
Case Series ◽  
Arachnoid Cysts ◽  
Middle Fossa ◽  
Ethical Considerations ◽  
Manic Symptoms

Arachnoid cysts have been linked to neuropsychiatric morbidity. We describe two patients presenting with dissociative and manic symptoms believed to be associated with middle fossa arachnoid cysts. They were managed medically and remitted eventually, but symptoms were resistant. We briefly review the literature to discuss mechanisms by which cysts could cause symptoms and consider whether neurosurgical management would be appropriate. Although neurosurgery can be considered, its role is currently limited by practical and ethical considerations.

Outcome of 12 antenatally diagnosed fetal arachnoid cysts: Case series and review of the literature

2015 ◽  
Vol 19 (2) ◽  
pp. 114-121 ◽  
Author(s):  
B. De Keersmaecker ◽  
P. Ramaekers ◽  
F. Claus ◽  
I. Witters ◽  
E. Ortibus ◽  
...  
Keyword(s):  
Case Series ◽  
Arachnoid Cysts ◽  
Review Of The Literature

Endoscopic cystoventriculostomy for treatment of paraxial arachnoid cysts

2009 ◽  
Vol 110 (4) ◽  
pp. 792-799 ◽  
Author(s):  
Joachim M. K. Oertel ◽  
Jörg Baldauf ◽  
Henry W. S. Schroeder ◽  
Michael R. Gaab
Keyword(s):  
Fourth Ventricle ◽  
Case Series ◽  
Arachnoid Cysts ◽  
Surgical Time ◽  
Cyst Size ◽  
Residual Symptoms ◽  
Surgical Case ◽  
Initial Procedure ◽  
The Mean

Object The optimal therapy of arachnoid cysts is controversial. In symptomatic extraventricular arachnoid cysts, fenestration into the basal cisterns is the gold standard. If this is not feasible, shunt placement is frequently performed although another endoscopic option is available. Methods Between March 1997 and June 2006, 12 endoscopic cystoventriculostomies were performed for the treatment of arachnoid cysts in 11 patients (4 male and 7 female patients, mean age 52 years [range 14–71 years]). All patients were prospectively followed up. Results In 11 cases, the arachnoid cysts were frontotemporoparietal and fenestration was performed into the lateral ventricle. In 1 case, the arachnoid cyst was located in the cerebellum and the cyst was fenestrated into the fourth ventricle. Neuronavigational guidance was used in all but 1 case. Endoscopic cystoventriculostomy was performed in all cases without complications. No stents were placed. The mean surgical time was 71 minutes (range 30–110 minutes). The mean follow-up period was 42.7 months (range 19–96 months) per surgical case and 48.8 months (range 19–127 months) per patient. Symptoms improved after 11 of the 12 procedures; 7 of the 11 patients became symptom-free and the others had only mild residual symptoms. The patient who did not experience clinical improvement suffered from depression and demonstrated a significant decrease of the cyst size on the postoperative MR imaging. After 11 of 12 procedures, a decrease in cyst size was observed. In 1 case, a subdural hematoma developed; it required surgical treatment 3 months after surgery. In another case, reclosure of the stoma required repeated endoscopic cystoventriculostomy more than 7 years after the initial procedure. Conclusions Overall, endoscopic cystoventriculostomy represents a useful treatment option for patients with paraxial arachnoid cysts in whom a standard cystocisternotomy is not feasible. Based on the results in this case series, stent placement appears not to be required. Despite the long mean follow-up of almost 4 years, however, a longer follow-up period seems to be required before definite conclusions can be drawn.

Medication Used in Neurologic Disorders Associated and/or Concomitant with Cerebral Arachnoid Cysts in Children

2018 ◽  
Vol 69 (1) ◽  
pp. 80-85
Author(s):  
Eva Maria Cojocaru ◽  
Victorita Stefanescu ◽  
Ariela Elena Banu ◽  
Aurel Nechita
Keyword(s):  
Case Series ◽  
Arachnoid Cysts ◽  
Migraine Treatment ◽  
Family Structures ◽  
Neurologic Disorder ◽  
Male Predominance ◽  
Neurologic Disorders ◽  
Different Types ◽  
Cerebral Cysts ◽  
First Time

Arachnoid cerebral cysts can create great anxiety to families of the affected child. In children prospective studies of arachnoid cerebral cyst series are focused on the surgical treatment and no medication associated tot this pathology was analysed until yet. We want to show how medication for neurological disorders found in children which have had also arachnoid cysts was used, and that not only surgery is the first line treatment in all types of arachnoid cysts.There are not extensive studies yet for the different contexts which are involving arachnoid cerebral cystsin children. This study was made for the first time in the cabinet of neurology from the Children Clinic Emergency Hospital Sfantul Ioan Galati in a 111 case series under clinic-imagistic surveillance and EEG between 2014-2017. A male predominance is seen as also a prevalence at the ages of 6-10 years of age and 2-5 years of age. Treatment were of different types due to the neurologic disorder which the children have had ( antiepileptic, neurotrophic, antiiinflammatory, nonsteroid and steroid and migraine treatment) after the international guidelines in use.The formulation of a diagnosis of epilepsy must be done with great responsibility because of many parioxistic nonepileptic events, where can exist associated arachnoid cysts, but we can have particulary family structures , because of the parents working places , so the waiting of the next paroxistic events and observing of the child is a wise attitude.But arachnoid cerebral cysts can be considered cerebral structural marker in some of the analysed cases.

Multiple sclerosis and psychiatric symptoms: a case series

2016 ◽  
Vol 26 ◽  
pp. S665-S666
Author(s):  
M.P. Calvo Rivera ◽  
L. Aguado Bailón ◽  
A. Porras Segovia ◽  
J. Cervilla Ballesteros
Keyword(s):  
Multiple Sclerosis ◽  
Psychiatric Symptoms ◽  
Case Series

scholarly journals Posterior fossa arachnoid cysts in adults: Surgical strategy: Case series

2015 ◽  
Vol 10 (1) ◽  
pp. 47 ◽  
Author(s):  
UddanapalliSreeramulu Srinivasan ◽  
Radhi Lawrence
Keyword(s):  
Posterior Fossa ◽  
Case Series ◽  
Surgical Strategy ◽  
Arachnoid Cysts

scholarly journals Arachnoid cysts: case series and review of the literature

2007 ◽  
Vol 22 (2) ◽  
pp. 1-4 ◽  
Author(s):  
Gustavo Pradilla ◽  
George Jallo
Keyword(s):  
Case Series ◽  
Cerebrospinal Fluid Leak ◽  
Senior Author ◽  
Arachnoid Cysts ◽  
Treatment Modalities ◽  
Johns Hopkins Hospital ◽  
Shunt Insertion ◽  
Stereotactic Aspiration ◽  
Recent Advances ◽  
Spinal Cysts

Object Arachnoid cysts are commonly encountered fluid collections in the central nervous system. Recent advances in neuroimaging have translated into an increased detection of these cysts; that is, diagnoses can be made more frequently at earlier stages. Significant advances have also been made in the surgical management of these lesions. The authors report on a case series that illustrates the diverse forms of presentation and the treatment modalities commonly used for arachnoid cysts. Methods Between January 2002 and December 2006, 20 patients with arachnoid cysts underwent surgery performed by the senior author at The Johns Hopkins Hospital. Seventy percent of the cysts were supratentorial, 5% infratentorial, and 25% spinal. All diagnoses were confirmed on neuroimaging, surgery, and histological examination. Included in the study were 12 male (60%) and eight female (40%) patients, ranging in age from 2 weeks to 39 years (mean age 10.9 years) at the time of surgery. Symptoms at presentation included headache (41%), weakness (23%), seizure (14%), hydrocephalus (9%), scoliosis (4%), cognitive decline (4%), and visual loss (4%). Twenty-five percent of the cysts were sylvian, 20% intraventricular, and 20% suprasellar. Supratentorial cysts were treated endoscopically in 73% of patients and with open resection in the remaining 27%. Complications included spasticity, hemiparesis, cerebrospinal fluid leak, hydrocephalus, and subdural hygroma. On follow-up evaluation, 60% of patients had stable cysts and improved symptoms, 13% complete symptom resolution, and 13% stable symptoms. All patients with spinal cysts underwent laminectomies and fenestration, and one cystosubarachnoid (CS) shunt was placed. Cyst reaccumulation occurred in three patients; two patients required cystoperitoneal (CP) and CS shunts. No deaths occurred. Conclusions Most arachnoid cysts are found incidentally and can be managed conservatively. Symptomatic patients are surgical candidates. Treatments include CP shunt placement, craniotomy, or endoscopic fenestration, and stereotactic aspiration. Recent advances in neurosurgical techniques and neuroendoscopy continue to favor fenestration over shunt insertion as the method of choice for initial cyst decompression.

scholarly journals GP.03 Immune deficiencies/dysregulations underpinning childhood limbic encephalitis: a case series and literature review

2018 ◽  
Vol 45 (s2) ◽  
pp. S8-S8 ◽  
Author(s):  
A Alawadhi ◽  
N Wilson ◽  
R Alizadehfar ◽  
G Sebire
Keyword(s):  
Literature Review ◽  
Limbic Encephalitis ◽  
Psychiatric Symptoms ◽  
Case Series ◽  
Thyroid Peroxidase ◽  
Retrospective Case ◽  
Temporal Epilepsy ◽  
Autoimmune Syndrome ◽  
Immune Deficiencies ◽  
Autistic Symptoms

Background: Limbic encephalitis (LE) is a rare autoimmune syndrome affecting limbic system structures and causing variety of manifestations including memory changes, temporal epilepsies, and psychiatric symptoms. It is a rare disease in children but with a well-recognizable combination of clinical, neuroimaging and/or histological signature. Beyond the association with anti-neuronal auto-antibodies, no clear immune system phenotype has been associated with limbic encephalitis. Our aim is to characterize the clinical and paraclinical features of non-paraneoplasic limbic encephalitis and to correlate them with potential underlying immune deficiencies. Methods: Retrospective case series of seven patients with limbic encephalitis recruited at the Montreal Children’s Hospital (MCH) with a focus on the immune- and neuro-phenotypes, including anti-neuronal antibodies, lymphocyte sub-typing, key markers of immunoglobulin and complement systems. Literature review showed 77 cases of non-paraneoplastic non-NMDA limbic encephalitis. Results: Symptoms included temporal epilepsy (n=5), psychiatric symptoms such as ADHD or autistic symptoms (n=2), and memory changes (n=3). One patient was positive for both voltage gated potassium channel antibodies (VGKC) and anti-thyroid peroxidase antibodies (TPO) and two were positive only for anti TPO antibodies. One patient showed low CD19, and immunoglobulins. Three patients showed chronic low CD56 cell count. Conclusions: The study is still ongoing, but at least 3 patients already display some traits of immune dysregulation.

Sign in / Sign up

Export Citation Format

Share Document